Commercial Supply ContractProthena Corp PLC • February 27th, 2017 • Pharmaceutical preparations
WHEREAS, Rentschler and Customer have entered into a Master Development Services Agreement dated August 10, 2015 (the “MDSA”) for certain development and manufacturing services for clinical purposes for Customer’s Product (as defined below);
SEPARATION AGREEMENTSeparation Agreement • February 27th, 2017 • Prothena Corp PLC • Pharmaceutical preparations • California
This Separation Agreement (this “Agreement”) by and between David B. McNinch (“Executive”) and Prothena Biosciences Inc, a Delaware corporation (the “Company”), is made effective as of the eighth (8th) day following the date Executive signs this Agreement (the “Effective Date”) with reference to the following facts:
